Role of plasma membrane defect of skeletal muscle in malignant hyperthermia

Aldrete JA, 1978, The Second International Symposium on Malignant Hyperthermia, 103

Anderson IL, 1978, Second International Symposium on Malignant Hyperthermia, 509

10.1177/00359157730661P133

10.1007/BF03026208

Britt BA, 1977, Malignant Hyperthermia: Current Concepts, 9

10.1038/254364a0

Bryant SH, 1977, Mechanical activation and electrophysiological properties of intercostal muscle fibers from malignant‐hyperthermia‐susceptible (MHS) pigs, Soc Neurosci, 30, 231

10.1093/bja/31.7.302

Ellis FR, 1971, Halothane‐induced muscle contracture as a cause of hyperprexia, Br J Anaesth, 43, 721

10.1007/BF00501011

10.1007/BF03006817

10.1097/00000542-197606000-00005

10.1097/00000542-197601000-00008

10.1093/bja/48.4.305

10.1093/bja/47.1.62

10.1097/00000542-197202000-00008

10.1097/00000542-196205000-00009

10.1093/bja/48.4.297

Morgan KG, 1977, The mechanism of action of dantrolene sodium, J Pharmacol Exp Ther, 201, 138

10.1097/00000542-197507000-00006

Nelson TE, Second International Symposium on Malignant Hyperthermia, 23

10.1111/j.1440-1681.1977.tb02628.x

Putney JW, 1974, Site of action of dantrolene in frog sartorius muscle, J Pharmacol Exp Ther, 189, 202

Raventós J, 1956, The action of Fluothane—a new volatile anaesthetic, Br J Anaesth, 11, 394

10.1007/BF00592693

10.2170/jjphysiol.25.747

10.1126/science.959824